XML 271 R84.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Additional Information to the Items of Profit or Loss - Schedule of Additional Information to the Items of Profit or Loss (Details) - USD ($) $ in Thousands | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021
a. Research and development expenses: |  |  |  |  |  |
Research and development expenses |  |  | $ 1,641 | $ 2,803 |  | $ 1,990
b. General and administrative expenses: |  |  |  |  |  |
General and administrative expenses |  |  | 5,031 | 5,972 |  | 3,778
c. Other expenses: |  |  |  |  |  |
Company’s share of losses of company accounted for at equity, net | $ 208 | $ 99 | 210 | 109 |  |
d. Finance income: |  |  |  |  |  |
Finance income | (323) | (1,024) | (2,219) | (7,832) |  |
e. Finance expenses: |  |  |  |  |  |
Finance expenses | $ 272 | $ 877 | 1,055 | 2,014 |  | 21
Wages and related expenses [Member] |  |  |  |  |  |
a. Research and development expenses: |  |  |  |  |  |
Research and development expenses |  |  | 392 | 436 |  | 357
b. General and administrative expenses: |  |  |  |  |  |
General and administrative expenses |  |  | 415 | 437 |  | 256
Share-based payment [Member] |  |  |  |  |  |
a. Research and development expenses: |  |  |  |  |  |
Research and development expenses |  |  | 34 | 264 |  | 27
b. General and administrative expenses: |  |  |  |  |  |
General and administrative expenses |  |  | 68 | 633 |  | 16
Regulatory, professional and other expenses [Member] |  |  |  |  |  |
a. Research and development expenses: |  |  |  |  |  |
Research and development expenses |  |  | 719 | 750 |  | 934
Research and preclinical studies [Member] |  |  |  |  |  |
a. Research and development expenses: |  |  |  |  |  |
Research and development expenses |  |  | 101 | 703 |  | 165
Clinical studies [Member] |  |  |  |  |  |
a. Research and development expenses: |  |  |  |  |  |
Research and development expenses |  |  | 254 | 369 |  | 172
Chemistry and formulations [Member] |  |  |  |  |  |
a. Research and development expenses: |  |  |  |  |  |
Research and development expenses |  |  | 141 | 281 |  | 335
Amazon Fees [Member] |  |  |  |  |  |
b. General and administrative expenses: |  |  |  |  |  |
General and administrative expenses |  |  | 1,042 | 424 |  |
Storage [Member] |  |  |  |  |  |
b. General and administrative expenses: |  |  |  |  |  |
General and administrative expenses |  |  | 145 | 90 |  |
Professional and directors’ fees [Member] |  |  |  |  |  |
b. General and administrative expenses: |  |  |  |  |  |
General and administrative expenses |  |  | 2,594 | 2,499 |  | 2,417
Business development expenses [Member] |  |  |  |  |  |
b. General and administrative expenses: |  |  |  |  |  |
General and administrative expenses |  |  | 86 | 161 |  | 5
Regulatory expenses [Member] |  |  |  |  |  |
b. General and administrative expenses: |  |  |  |  |  |
General and administrative expenses |  |  | 202 | 162 |  | 165
Office maintenance, rent and other expenses [Member] |  |  |  |  |  |
b. General and administrative expenses: |  |  |  |  |  |
General and administrative expenses |  |  | 110 | 80 | [1] | 135
Investor relations and business expenses [Member] |  |  |  |  |  |
b. General and administrative expenses: |  |  |  |  |  |
General and administrative expenses |  |  | 369 | 1,486 |  | 784
Net change in fair value of financial liabilities designated at fair value through profit or loss [Member] |  |  |  |  |  |
d. Finance income: |  |  |  |  |  |
Finance income |  |  | (2,205) | (7,832) |  |
Exchange rate differences, net [Member] |  |  |  |  |  |
d. Finance income: |  |  |  |  |  |
Finance income |  |  | (14) |  |  |
e. Finance expenses: |  |  |  |  |  |
Finance expenses |  |  |  | 4 |  | 3
Issuance expenses related to warrants [Member] |  |  |  |  |  |
e. Finance expenses: |  |  |  |  |  |
Finance expenses |  |  |  | 1,204 |  | 6
Losses from remeasurement of investment in financial assets [Member] |  |  |  |  |  |
e. Finance expenses: |  |  |  |  |  |
Finance expenses |  |  | 1,046 | 770 |  |
Finance expense in respect of leases [Member] |  |  |  |  |  |
e. Finance expenses: |  |  |  |  |  |
Finance expenses |  |  | 9 | 15 |  | 4
Finance expenses from interest and commissions [Member] |  |  |  |  |  |
e. Finance expenses: |  |  |  |  |  |
Finance expenses |  |  |  | $ 21 |  | $ 8
[1] | Reclassified to correlate with common practice in industry and better reflect profit and loss.

X
- Definition The amount of costs associated with financing activities of the entity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 82 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_FinanceCosts
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of income associated with interest and other financing activities of the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 85 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_85&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_FinanceIncome
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of expense relating to selling, general and administrative activities of the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 85 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_85&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_SellingGeneralAndAdministrativeExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_AResearchAndDevelopmentExpensesAbstract
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_BGeneralAndAdministrativeExpensesAbstract
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_COtherExpensesAbstract
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Company’s share of losses of company accounted for at equity, net. + References No definition available. + Details
Name: | sprcy_CompanysShareOfLossesOfCompanyAccountedForAtEquityNet
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_DFinanceIncomeAbstract
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_EFinanceExpensesAbstract
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. + References No definition available. + Details
Name: | sprcy_ResearchAndDevelopmentExpenses1
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_WagesAndRelatedExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ShareBasedPaymentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_RegulatoryProfessionalAndOtherExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ResearchAndPreclinicalStudiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ClinicalStudiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ChemistryAndFormulationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_AmazonFeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_StorageMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ProfessionalAndDirectorsFeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_BusinessDevelopmentExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_RegulatoryExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_OfficeMaintenanceRentAndOtherExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_InvestorRelationsAndBusinessExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_NetChangeInFairValueOfFinancialLiabilitiesDesignatedAtFairValueThroughProfitOrLossMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ExchangeRateDifferencesNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_IssuanceExpensesRelatedToWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_LossesFromRemeasurementOfInvestmentInFinancialAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_FinanceExpenseInRespectOfLeasesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_FinanceExpensesFromInterestAndCommissionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |